Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

vs
industry
vs
history
Cash to Debt 0.02
NIMU's Cash to Debt is ranked lower than
59% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.27 vs. NIMU: 0.02 )
NIMU' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.02

Equity to Asset -3.02
NIMU's Equity to Asset is ranked lower than
58% of the 453 Companies
in the Global Medical Devices industry.

( Industry Median: 0.64 vs. NIMU: -3.02 )
NIMU' s 10-Year Equity to Asset Range
Min: -7   Max: 0.91
Current: -3.02

-7
0.91
Interest Coverage No Debt
NIMU's Interest Coverage is ranked higher than
89% of the 257 Companies
in the Global Medical Devices industry.

( Industry Median: 241.11 vs. NIMU: No Debt )
NIMU' s 10-Year Interest Coverage Range
Min: 9999.99   Max: 9999.99
Current: No Debt

F-Score: 4
Z-Score: -67.87
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

vs
industry
vs
history
Operating margin (%) -2407.69
NIMU's Operating margin (%) is ranked lower than
57% of the 458 Companies
in the Global Medical Devices industry.

( Industry Median: 5.49 vs. NIMU: -2407.69 )
NIMU' s 10-Year Operating margin (%) Range
Min: -2407.69   Max: 11.24
Current: -2407.69

-2407.69
11.24
Net-margin (%) -3400.00
NIMU's Net-margin (%) is ranked lower than
57% of the 458 Companies
in the Global Medical Devices industry.

( Industry Median: 3.95 vs. NIMU: -3400.00 )
NIMU' s 10-Year Net-margin (%) Range
Min: -3407.69   Max: 12.06
Current: -3400

-3407.69
12.06
ROA (%) -69.11
NIMU's ROA (%) is ranked lower than
51% of the 475 Companies
in the Global Medical Devices industry.

( Industry Median: 2.61 vs. NIMU: -69.11 )
NIMU' s 10-Year ROA (%) Range
Min: -276.87   Max: 12.46
Current: -69.11

-276.87
12.46
ROC (Joel Greenblatt) (%) -13041.67
NIMU's ROC (Joel Greenblatt) (%) is ranked lower than
58% of the 473 Companies
in the Global Medical Devices industry.

( Industry Median: 8.37 vs. NIMU: -13041.67 )
NIMU' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -10433.33   Max: 58.24
Current: -13041.67

-10433.33
58.24
Revenue Growth (%) -100.00
NIMU's Revenue Growth (%) is ranked lower than
54% of the 339 Companies
in the Global Medical Devices industry.

( Industry Median: 5.40 vs. NIMU: -100.00 )
NIMU' s 10-Year Revenue Growth (%) Range
Min: 0   Max: 35.7
Current: -100

0
35.7
EBITDA Growth (%) -100.00
NIMU's EBITDA Growth (%) is ranked lower than
52% of the 306 Companies
in the Global Medical Devices industry.

( Industry Median: 0.60 vs. NIMU: -100.00 )
NIMU' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 44.2
Current: -100

0
44.2
EPS Growth (%) -20.60
NIMU's EPS Growth (%) is ranked higher than
61% of the 297 Companies
in the Global Medical Devices industry.

( Industry Median: 2.20 vs. NIMU: -20.60 )
NIMU' s 10-Year EPS Growth (%) Range
Min: 0   Max: 534.1
Current: -20.6

0
534.1
» NIMU's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with NIMU

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 880.51
NIMU's P/S is ranked lower than
54% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 3.40 vs. NIMU: 880.51 )
NIMU' s 10-Year P/S Range
Min: 2.25   Max: 104
Current: 880.51

2.25
104
EV-to-EBIT -40.40
NIMU's EV-to-EBIT is ranked higher than
60% of the 511 Companies
in the Global Medical Devices industry.

( Industry Median: 73.45 vs. NIMU: -40.40 )
NIMU' s 10-Year EV-to-EBIT Range
Min: 23.5   Max: 692.3
Current: -40.4

23.5
692.3
Current Ratio 0.25
NIMU's Current Ratio is ranked lower than
58% of the 474 Companies
in the Global Medical Devices industry.

( Industry Median: 2.72 vs. NIMU: 0.25 )
NIMU' s 10-Year Current Ratio Range
Min: 0.19   Max: 7.28
Current: 0.25

0.19
7.28
Quick Ratio 0.03
NIMU's Quick Ratio is ranked lower than
59% of the 474 Companies
in the Global Medical Devices industry.

( Industry Median: 1.95 vs. NIMU: 0.03 )
NIMU' s 10-Year Quick Ratio Range
Min: 0.03   Max: 6.82
Current: 0.03

0.03
6.82

Valuation & Return

vs
industry
vs
history
Earnings Yield (Greenblatt) -2.50
NIMU's Earnings Yield (Greenblatt) is ranked higher than
63% of the 464 Companies
in the Global Medical Devices industry.

( Industry Median: 2.40 vs. NIMU: -2.50 )
NIMU' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.1   Max: 4.3
Current: -2.5

0.1
4.3
Forward Rate of Return (Yacktman) -34.31
NIMU's Forward Rate of Return (Yacktman) is ranked higher than
54% of the 349 Companies
in the Global Medical Devices industry.

( Industry Median: 0.59 vs. NIMU: -34.31 )
NIMU' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -57.8   Max: -1.3
Current: -34.31

-57.8
-1.3

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Non-Invasive Monitoring Systems, Inc. was incorporated under the laws of the State of Florida on July 16, 1980. The Company, together with its subsidiaries, engages in the research, development, manufacture, and marketing of non-invasive, motorized, and whole body periodic acceleration platforms in the United States. The Company provides Exer-Rest line of acceleration therapeutic platforms that include the Exer-Rest AT3800 and the Exer-Rest AT4700; and LifeShirt, a wearable physiological computer that incorporates transducers, electrodes, and sensors into a sleeveless garment. It also has licenses for its non-invasive diagnostic monitoring devices and related software products. The Company markets the Exer-Rest platforms to hospitals, cardiac rehabilitation clinics, chiropractic and physical therapy centers, senior living communities, and other healthcare providers, as well as to their patients, professional athletes, and other individuals.

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK